메뉴 건너뛰기




Volumn 33, Issue 2, 2005, Pages 99-103

Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: Results from a randomized comparative trial: (Novavir ANRS 073)

Author keywords

Mutations; Nucleosides RT inhibitors; Protease inhibitors; Randomized trial; Resistance

Indexed keywords

DIDANOSINE; DRUG METABOLITE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; THYMIDINE; ZALCITABINE; ZIDOVUDINE;

EID: 21144449047     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.05.019     Document Type: Article
Times cited : (4)

References (18)
  • 1
    • 10344263394 scopus 로고    scopus 로고
    • Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
    • J.H. Condra, D.J. Holder, W.A. Schleif, O.M. Blahy, R.M. Danovich, and L.J. Gabryelski Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor J Virol 70 1996 8270 8276
    • (1996) J Virol , vol.70 , pp. 8270-8276
    • Condra, J.H.1    Holder, D.J.2    Schleif, W.A.3    Blahy, O.M.4    Danovich, R.M.5    Gabryelski, L.J.6
  • 3
    • 0034639473 scopus 로고    scopus 로고
    • Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy Trilege (Agence Nationale de Recherches sur le SIDA 072 Study Team)
    • D. Descamps, P. Flandre, V. Calvez, G. Peytavin, V. Meiffredy, and G. Collin Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy Trilege (Agence Nationale de Recherches sur le SIDA 072 Study Team) JAMA 283 2000 205 211
    • (2000) JAMA , vol.283 , pp. 205-211
    • Descamps, D.1    Flandre, P.2    Calvez, V.3    Peytavin, G.4    Meiffredy, V.5    Collin, G.6
  • 4
    • 0035823002 scopus 로고    scopus 로고
    • Drug resistance in patients experiencing early virological failure under a triple combination including indinavir
    • O. Gallego, C. de Mendoza, M.J. Perez-Elias, J.M. Guardiola, J. Pedreira, and D. Dalmau Drug resistance in patients experiencing early virological failure under a triple combination including indinavir AIDS 15 2001 1701 1706
    • (2001) AIDS , vol.15 , pp. 1701-1706
    • Gallego, O.1    De Mendoza, C.2    Perez-Elias, M.J.3    Guardiola, J.M.4    Pedreira, J.5    Dalmau, D.6
  • 5
    • 0034639490 scopus 로고    scopus 로고
    • Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
    • D.V. Havlir, N.S. Hellmann, C.J. Petropoulos, J.M. Whitcomb, A.C. Collier, and M.S. Hirsch Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens JAMA 283 2000 229 234
    • (2000) JAMA , vol.283 , pp. 229-234
    • Havlir, D.V.1    Hellmann, N.S.2    Petropoulos, C.J.3    Whitcomb, J.M.4    Collier, A.C.5    Hirsch, M.S.6
  • 6
    • 0038234808 scopus 로고    scopus 로고
    • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel
    • M.S. Hirsch, F. Brun-Vezinet, B. Clotet, B. Conway, D.R. Kuritzkes, and R.T. D'Aquila Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel Clin Infect Dis 37 2003 113 128
    • (2003) Clin Infect Dis , vol.37 , pp. 113-128
    • Hirsch, M.S.1    Brun-Vezinet, F.2    Clotet, B.3    Conway, B.4    Kuritzkes, D.R.5    D'Aquila, R.T.6
  • 8
    • 0036090626 scopus 로고    scopus 로고
    • Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial)
    • V. Joly, P. Flandre, V. Meiffredy, F. Brun-Vezinet, J.A. Gastaut, and C. Goujard Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial) Antimicrob Agents Chemother 46 2002 1906 1913
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1906-1913
    • Joly, V.1    Flandre, P.2    Meiffredy, V.3    Brun-Vezinet, F.4    Gastaut, J.A.5    Goujard, C.6
  • 9
    • 0002084094 scopus 로고    scopus 로고
    • Drug resistance testing: Time to be used in clinical practice
    • D. Kuritzkes Drug resistance testing: time to be used in clinical practice AIDS Rev 1 1999 45 50
    • (1999) AIDS Rev , vol.1 , pp. 45-50
    • Kuritzkes, D.1
  • 10
    • 0032704706 scopus 로고    scopus 로고
    • Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection
    • C. Lamotte, G. Peytavin, and R. Farinotti Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection J Chromatogr B Biomed Sci Appl 735 1999 159 170
    • (1999) J Chromatogr B Biomed Sci Appl , vol.735 , pp. 159-170
    • Lamotte, C.1    Peytavin, G.2    Farinotti, R.3
  • 11
    • 0033946694 scopus 로고    scopus 로고
    • Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: Virological evaluation of the AVANTI 2 and AVANTI 3 studies
    • M. Maguire, M. Gartland, S. Moore, A. Hill, M. Tisdale, and R. Harrigan Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies AIDS 14 2000 1195 2001
    • (2000) AIDS , vol.14 , pp. 1195-2001
    • Maguire, M.1    Gartland, M.2    Moore, S.3    Hill, A.4    Tisdale, M.5    Harrigan, R.6
  • 12
    • 0036174439 scopus 로고    scopus 로고
    • Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: Selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors
    • M. Maguire, D. Shortino, A. Klein, W. Harris, V. Manohitharajah, and M. Tisdale Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors Antimicrob Agents Chemother 46 2002 731 738
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 731-738
    • Maguire, M.1    Shortino, D.2    Klein, A.3    Harris, W.4    Manohitharajah, V.5    Tisdale, M.6
  • 13
    • 15444377672 scopus 로고    scopus 로고
    • Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
    • A. Molla, M. Korneyeva, Q. Gao, S. Vasavanonda, P.J. Schipper, and H.M. Mo Ordered accumulation of mutations in HIV protease confers resistance to ritonavir Nat Med 2 1996 760 766
    • (1996) Nat Med , vol.2 , pp. 760-766
    • Molla, A.1    Korneyeva, M.2    Gao, Q.3    Vasavanonda, S.4    Schipper, P.J.5    Mo, H.M.6
  • 14
    • 0033929132 scopus 로고    scopus 로고
    • Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance
    • M. Mouroux, A. Yvon-Groussin, G. Peytavin, C. Delaugerre, M. Legrand, and P. Bossi Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance J Clin Microbiol 38 2000 2726 2730
    • (2000) J Clin Microbiol , vol.38 , pp. 2726-2730
    • Mouroux, M.1    Yvon-Groussin, A.2    Peytavin, G.3    Delaugerre, C.4    Legrand, M.5    Bossi, P.6
  • 16
    • 0032750954 scopus 로고    scopus 로고
    • Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies
    • E. Race, E. Dam, V. Obry, S. Paulous, and F. Clavel Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies AIDS 13 1999 2061 2068
    • (1999) AIDS , vol.13 , pp. 2061-2068
    • Race, E.1    Dam, E.2    Obry, V.3    Paulous, S.4    Clavel, F.5
  • 17
    • 0028896468 scopus 로고
    • Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching
    • E. Woolf, T. Au, H. Haddix, and B. Matuszewski Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching J Chromatogr A 692 1995 45 52
    • (1995) J Chromatogr a , vol.692 , pp. 45-52
    • Woolf, E.1    Au, T.2    Haddix, H.3    Matuszewski, B.4
  • 18
    • 0035659914 scopus 로고    scopus 로고
    • Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir
    • S. Yerly, M. Rickenbach, M. Popescu, P. Taffe, C. Craig, and L. Perrin Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir Antivir Ther 6 2001 185 189
    • (2001) Antivir Ther , vol.6 , pp. 185-189
    • Yerly, S.1    Rickenbach, M.2    Popescu, M.3    Taffe, P.4    Craig, C.5    Perrin, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.